Virology News and Research

Latest Virology News and Research

Viruses modify host cellular machinery to produce high amounts of viral progeny

The study, published in Nature Communications, shows a new mechanism whereby viruses modify cellular machinery so that it can better read the instructions in the genome of the invading virus.

29 Aug 2022

COVID-19 pandemic: An epidemiological update

Epidemics and pandemics have been frightening the human chase again and again. SARS, H1N1, Ebola, and more have exposed their real face in the past, but with every such outbreak.

25 Aug 2022

Study finds link between high-density lipoprotein and COVID-19

A new study has highlighted the significance of high-density lipoprotein COVID-19 pathogenesis and outcome.

24 Aug 2022

SARS-CoV-2 variants of concern emerging from chronic COVID infections, study shows

The coronavirus variants of concern are emerging from chronic, long-term COVID infections in people who may be immune comprised and unable to clear the virus, a new study strongly suggests.

23 Aug 2022

Marburg outbreak in Ghana causes African countries to stay alert

Africa must ramp up its surveillance and detection infrastructure in the light of an outbreak of the deadly Marburg virus in Ghana, public health leaders have warned.

23 Aug 2022

A practical guide for monkeypox diagnosis, prevention and treatment

Researchers provide an overview of the monkeypox infection in light of the current COVID-19 pandemic.

22 Aug 2022

Non-nutritive sweeteners cause changes in the gut microbes and impact glucose tolerance

Since the late 1800s non-nutritive sweeteners have promised to deliver all the sweetness of sugar with none of the calories.

19 Aug 2022

New study estimates how long people with mild COVID-19 are infectious

A new study of 57 people with mild COVID-19 estimates how long people are infectious for and when they can safely leave isolation.

19 Aug 2022

Acid ceramidase is a SARS-CoV-2 host factor, study says

Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at Julius-Maximilians-Universität (JMU) Würzburg in the summer of 2020. However, the mechanism of this inhibition was utterly unclear, so the teams continued their research.

17 Aug 2022

Study provides insights into understanding the biology of circulating Hepatitis E variants

Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are important for the virus in the course of its replication cycle and how it manages to maintain the infection.

17 Aug 2022

CSU part of $12.5 million-supported institute to advance virus research and education

Colorado State University researchers are part of a $12.5 million National Science Foundation-supported institute that will advance research and education around viral emergence – the process of viruses jumping from animals to humans.

16 Aug 2022

Research progress on the three-dimensional interaction between virus and host genome

A recent study reviewed the current progress on 3D interactions between host and viral genomes.

8 Aug 2022

Researchers identify new therapies that could provide better protection against future COVID-19 variants

Researchers from the University of Kent in Canterbury, UK and the Goethe-University in Frankfurt am Main have identified new therapies for COVID-19 that could provide better protection against future variants and outbreaks.

8 Aug 2022

ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval

"Welcome to ViruStop!" Recently, ACROBiosystems officially announced the launch of a new brand, ViruStop. ViruStop is specifically designed for virus research and development, committing to accelerating the process of infectious diseases vaccine research, development and approval.

From ACROBiosystems 1 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

In our latest interview, News-Medical speaks to Simon Parker, an infectious disease specialist, about hepatitis C diagnostics and testing, as well as why the global fight against hepatitis cannot wait.

28 Jul 2022

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting a dose up the nose has an advantage over a shot.

27 Jul 2022

Study finds specific molecular barriers to SARS-CoV-2 replication in bat cells

Bat cells have specific molecular barriers to deal with SARS-CoV-2 replication, according to a study published in Journal of Virology —publication of the American Society of Microbiology— which includes the participation of Jordi Serra-Cobo, lecturer of the Faculty of Biology and the Biodiversity Research Institute (IRBio) of the University of Barcelona and expert on ecoepidemiological studies.

27 Jul 2022

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

Finding a cure for HIV has been extremely difficult, in part because the virus hides from antiretroviral treatments in one of the hardest places to reach: the brain.

27 Jul 2022

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Researchers report the efficacy and safety of molnupiravir in treating COVID-19.

26 Jul 2022

Virology News and Research

Latest Virology News and Research

Viruses modify host cellular machinery to produce high amounts of viral progeny

COVID-19 pandemic: An epidemiological update

Study finds link between high-density lipoprotein and COVID-19

SARS-CoV-2 variants of concern emerging from chronic COVID infections, study shows

Marburg outbreak in Ghana causes African countries to stay alert

A practical guide for monkeypox diagnosis, prevention and treatment

Non-nutritive sweeteners cause changes in the gut microbes and impact glucose tolerance

New study estimates how long people with mild COVID-19 are infectious

Acid ceramidase is a SARS-CoV-2 host factor, study says

Study provides insights into understanding the biology of circulating Hepatitis E variants

CSU part of $12.5 million-supported institute to advance virus research and education

Research progress on the three-dimensional interaction between virus and host genome

Researchers identify new therapies that could provide better protection against future COVID-19 variants

ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

Study finds specific molecular barriers to SARS-CoV-2 replication in bat cells

Scientists receive $3.9 million NIH grant to eradicate HIV from the brain

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up